a company which offers pre-clinical drug discovery and development solutions
Industry Biotechnology
A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then DNLI could also see price increases.
Ticker / NAME | Correlation To RCUS | 1D Price Change % | ||
---|---|---|---|---|
RCUS | 100% | -2.03% | ||
DNLI - RCUS | 50% Loosely correlated | -0.87% | ||
ACLX - RCUS | 48% Loosely correlated | -0.34% | ||
ALEC - RCUS | 48% Loosely correlated | -7.66% | ||
PLRX - RCUS | 46% Loosely correlated | -0.36% | ||
RXRX - RCUS | 46% Loosely correlated | -3.43% | ||
More |
Ticker / NAME | Correlation To RCUS | 1D Price Change % |
---|---|---|
RCUS | 100% | -2.03% |
drugs theme (254 stocks) | 59% Loosely correlated | -1.72% |
pharmaceuticals theme (159 stocks) | 50% Loosely correlated | -1.94% |